BusinessfromFortune22 hours agoGSK chief doesn't buy that the CEO role has become unsustainable | FortuneGSK CEO Emma Walmsley rejects the co-CEO model, urging CEOs to fully commit to a single leadership role despite its demands.
Businessfromwww.theguardian.com2 weeks agoPharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing business liveGSK appoints Luke Miels as CEO Designate to succeed Emma Walmsley, effective 1 January 2026, after nine years and a company overhaul.